The briefing
According to the American College of Allergy, Asthma & Immunology, a review of 326 biologic prescriptions at a children’s hospital from 2018–2026 found that insurance denials and delays impeded access to needed treatments. The findings highlight administrative hurdles that can worsen outcomes for pediatric patients with severe allergies and asthma.
Original headline
Insurance Delays and Denials Mean Kids Don’t Get Allergy and Asthma Medications